SHAREHOLDER ALERT: WeissLaw LLP Reminds LACQ, VCVC, GWPH, and PRSP Shareholders About Its Ongoing Investigations

NEW YORK, Feb. 10, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16^th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
[email protected]

Leisure Acquisition Corp. (NASDAQ: LACQ)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Leisure Acquisition Corp. (NASDAQ: LACQ), in connection with the Company's proposed merger with Ensysce Biosciences, Inc. ("Ensysce").  Under the terms of the merger agreement, Leisure will acquire Ensyce through a reverse merger that will result in Ensysce becoming a public company traded on the NASDAQ.  If you own LACQ shares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/lacq/ 

10X Capital Venture Acquisition Corp. (NASDAQ: VCVC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of 10X Capital Venture Acquisition Corp. (NASDAQ: VCVC) in connection with the Company's proposed merger with REE Automotive Ltd. ("REE"), a privately-held automotive technology company.  Under the terms of the merger agreement, VCVC will acquire REE through a reverse merger that will result in REE becoming a public company traded on the NASDAQ.  If you own VCVC shares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/vcvc/ 

GW Pharmaceuticals plc (NASDAQ: GWPH)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GW Pharmaceuticals plc (NASDAQ: GWPH) in connection with the proposed acquisition of the Company by Jazz Pharmaceuticals Public Limited Company ("Jazz").  Under the terms of the merger agreement, Jazz will acquire GWPH in a mixed cash-and-stock transaction for $220.00 per American Depositary Share ("ADS"), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares.  If you own GWPH shares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/gwph/ 

Perspecta Inc. (NYSE: PRSP) 

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Perspecta Inc. (NYSE: PRSP) in connection with the proposed acquisition of the company by Peraton, a portfolio company of Veritas Capital.  Under the terms of the merger agreement, PRSP shareholders will receive $29.35 in cash for each share of PRSP common stock that they hold.  If you own PRSP shares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/prsp/ 

SOURCE WeissLaw LLP

Related Links

http://weisslawllp.com